Johnson & Johnson Vision announced that 21 company-sponsored studies supporting cataract surgery outcomes will be presented at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) and American Society of Ophthalmic Administrators (ASOA) Annual Meeting in Las Vegas Nevada, July 23-27, 2021. A complete listing of abstracts related to Johnson & Johnson Vision can be found on the ASCRS website.
“We’re passionate about developing evidenced-based solutions that surgeons use to improve their patients’ sight and wellbeing, as well as evaluating the clinical outcomes of those innovations,” Rajesh Rajpal, MD, Chief Medical Officer and Global Head of Clinical and Medical Affairs, Johnson & Johnson Vision, said in a company news release. “This year at ASCRS we’ve more than tripled our presentations, offering a robust slate of clinical data, including data for our new Tecnis Synergy IOL2 and postmarket data evaluating the rotational stability of theTecnis Toric II IOLs,1 as we know it will be beneficial for surgeons to consider when they are determining their cataract patients’ treatment plans.”
At the meeting, Johnson & Johnson Vision will also feature the new monofocal and PC-IOL lenses introduced this year, and its next-gen phaco emulsification system that received FDA 510(k) clearance earlier this year at its booth (#2813), host a case-based discussion on the new TECNIS Synergy IOL, and help bring the diverse ophthalmology community back together by sponsoring the OWL organization’s Signature Event. Additionally, a skills transfer wet-lab for Veritas Vision System will be featured in the Johnson & Johnson Vision booth, allowing customers to be among the first in the United States to receive hands-on experience with the system.
Evidence Supports Excellent Visual Performance and Rotational Stability with Tecnis IOLs
Visual acuity, contrast sensitivity, and depth perception are highly interrelated elements of vision and impact health-related quality of life and safety. IOL data being presented utilize novel rotation measurement method to evaluate rotational stability of the Tecnis Synergy Toric II IOL,1 and reviews head-to-head data for the Tecnis Synergy IOL, showing the lenses deliver excellent performance, image contrast, and outcomes for cataract patients.2
- Paper Presentation: “Clinical Comparison Between a New Diffractive Presbyopia-Correcting IOL and a Trifocal IOL: 6-Month Clinical Results.” Corbett D; Vargas L (Abstract #50129)
Sunday, July 25, 2021, 10:45 AM – 10:50 AM, MBCR – Level 2, Lagoon EF
- Paper Presentation: “Clinical Investigation of the Rotational Stability of a Modified Single-Piece Acrylic Toric Intraocular Lens.” Miller K. (Abstract #50126)
Monday, July 26, 2021, 4:35 PM – 4:40 PM, MBCR – Level 2, Surf AB
Data Shows TearScience LipiFlow Treatment Prior to Cataract Surgery Optimizes Outcomes
The incidence of ocular surface disease in patients presenting for cataract surgery is over 80% and 60% of cataract surgery candidates are asymptomatic. In alignment with current ASCRS clinical guidelines, the proactive diagnosis and management of MGD in the preoperative cataract patient is recommended. Data presented evaluates the improvements in visual acuity, reporting of halos, and improvement of MGD function in patients treated prior to bilateral cataract surgery.
- Poster Presentation: “Preoperative Treatment of Meibomian Gland Dysfunction with Thermal Pulsation System Prior to Extended Depth of Focus IOL Implantation.” Hu, J. (Abstract #50132)
Evaluation Demonstrates Improved Performance of Veritas Vision System Fluidics Packs
Anterior chamber stability is key to successful outcomes for patients undergoing cataract surgery, while post-occlusion surge is a main source of chamber instability during cataract surgery. Optimal fluidics management may reduce complication rates. Key data will assess if the new Hybrid Fluidics Technology on the Veritas Vision System minimize post-occlusion surge and protects intraocular structures to provide exceptional chamber stability.
- Paper Presentation: “Assessment of Small-Bore, Dual-Durometer Aspiration Tubing in a New Dual Mode Phacoemulsification System.” Chetan P. (Abstract #50137)
Saturday, July 24, 2021, 3:50 PM – 3:55 PM, MBCR – Level 2, Lagoon EF
All educational content of the ASCRS•ASOA Annual Meeting is planned by its program committee, and ASCRS•ASOA does not endorse, promote, approve, or recommend the use of any products, devices, or services.
[ii] DOF2020CT4014 – Forte 1: A Comparative Clinical Evaluation of a New TECNIS® Presbyopia Correcting Intraocular Lens Against a PanOptix® Intraocular Lens- DEFOCUS CURVES AND VISUAL ACUITY RESULTS
[iii] DOF2020CT4015- (“Forte 1”): A Comparative Clinical Evaluation of a New TECNIS® Presbyopia Correcting Intraocular Lens Against a PanOptix® Intraocular Lens- SPECTACLE WEAR AND SATISFACTION RESULTS
[iv] Shader RI (2019) Falls, Frailty, Vision, and Aging. Clin Ther 41 (3): 369-372.
[v] Datta S, Foss AJ, Grainge MJ, Gregson RM, Zaman A et al. (2008) The importance of acuity, stereopsis, and contrast sensitivity for health-related quality of life in elderly women with cataracts. Invest Ophthalmol Vis Sci 49 (1): 1-6.
[vi] Johnson & Johnson Vision. DOF2021CT4012 v1.0
[vii] DOF2021MLT40003 TearScience® LipiFlow® (Tahoe Study)
[viii] Gupta, P K.; Drinkwater, O; VanDusen, K; Brissette, A; Starr, C. Prevalence of ocular surface dysfunction in patients presenting for cataract surgery evaluation. J Catarct Refract Surg 2018; 44:1090-1096
[ix] Trattler WB, Majmundar PA, Donnenfeld ED, McDonald MB, Stonecipher KG, Goldberg DF. The Prospective Health Assessment of Cataract Patients Ocular Surface (PHACO) study: the effect of dry eye. Clin Ophthalmol 2017; 11:1423-1430.
[x] Starr C, et al. The ASCRS Cornea Clinical Committee. An algorithm for the preoperative diagnosis and treatment of ocular
surface disorders. J Cataract Refract Surg. 2019;45:669-684).
[xi] Nicoli M, Dimalanta R, Miller K (2016) Experimental anterior chamber maintenance in active versus passive phacoemulsification fluidics systems. J Cataract Refract Surg 42: 157-162.
[xii] Chang D (2008) Improving Surgical Safety With Modern Phaco Technology. Cat & Refr Surg Today 11; 1-3.
[xiii] Zeng M, Wang R, Cheng B, Yang C, Chen Y, Liu X (2020) Effectiveness of operative intraocular lens use on improving surgical safety for dense cataract phacoemulsification: a randomized controlled trial. Sci Rep 10, 1600. doi.org/10.1038/s41598-020-58597-0.
[xiv] Benjamin L (2018) Fluidics and rheology in phaco surgery: what matters and what is the hype? Eye; 32: 204-209.